Nasus Pharma Ltd.
Organization details
- Legal name
- Nasus Pharma Ltd.
- Ownership
- Public
- Status
- Active
- Sector (GICS)
- Health Care
- SIC code
- 2834 — Pharmaceutical Preparations
- Jurisdiction of incorporation
- Israel
- Headquarters city
- TEL Aviv - Yafo
- Fiscal year end
- December
- Ticker symbol
- NSRX
- Primary stock exchange
- NYSE American
Identifiers
- SEC CIK
- 0002029039
- EIN
- 51-6022712
Board of directors
-
Brendan P. O'Grady · Director · Chief Executive OfficerSince 2026
-
Dalia Megiddo · Director · Chief Development OfficerSince 2026
-
Dan Benjamin Teleman · Director · Chief Executive OfficerSince 2026
-
David Silberman · DirectorSince 2026
-
Isaac Israel · DirectorSince 2026
-
Ronnie Hershman · DirectorSince 2026
-
Sharon Shacham · DirectorSince 2026
Chief executives
Board connections
1 of this board's directors also sit on 1 other board. 1 is in the same sector.
-
Acrivon Therapeutics Inc. Same sectorvia Sharon Shacham
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
- Bought, last 12 months
- $61,809
- 3 purchases by 1 insider
- Sold, last 12 months
- $0
- 0 sales by 0 insiders
| Date | Insider | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Jun 17, 2026 | Dan Benjamin Teleman Director, Officer (Chief Executive Officer) | Open-market purchase | +6,550 | $3.10 | $20,305 |
| Apr 22, 2026 | Dan Benjamin Teleman Director, Officer (Chief Executive Officer) | Open-market purchase | +2,900 | $3.76 | $10,904 |
| Mar 31, 2026 | Dan Benjamin Teleman Director, Officer (Chief Executive Officer) | Open-market purchase | +15,000 | $2.04 | $30,600 |
Peers
Compare boardsOrganizations in the same sector, closest in location and size first.
Questions about Nasus Pharma Ltd.
Who is the CEO of Nasus Pharma Ltd.?
Brendan P. O'Grady has been Nasus Pharma Ltd.'s Chief Executive Officer since July 2026.
How many directors are on Nasus Pharma Ltd.'s board?
Nasus Pharma Ltd.'s board has 7 directors: Brendan P. O'Grady, Dalia Megiddo, Dan Benjamin Teleman, David Silberman, Isaac Israel, Ronnie Hershman and Sharon Shacham.
Are Nasus Pharma Ltd. insiders buying or selling shares?
Over the last 12 months, Nasus Pharma Ltd. insiders bought $61,809 of shares in 3 purchases and made no open-market sales on the open market, as reported to the SEC on Forms 4 and 5.
Embed this board on your site
Paste this where the board should appear. It always shows the current directors and links back here.
<div data-bod-board="nasus-pharma-ltd"></div>
<script src="https://boardofdirectors.review/embed.js" async></script>Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.